Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Postdoctoral Fellow

Molecular And Cellular Pathology · China · 2024-08-30

Processing Time
311 days
Decision Date
2024-08-30
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance the understanding of the role of vascular smooth muscle cells in cardiovascular disorders. This work utilizes expertise in epigenome editing and profiling, vascular calcification, and reproductive toxicology to improve public health outcomes and therapeutic strategies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses cardiovascular disorders and public health, which are of significant value to the nation.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., extensive publication record, and high citation count demonstrate they are well-positioned.

3 Balance of Factors Met

On balance, the petitioner's unique expertise in epigenome editing makes it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the client's Ph.D. and authorship of 16 peer-reviewed journal articles and 6 abstracts which garnered 477 citations. Additionally, the client completed 42 peer reviews for leading journals and secured support from four expert recommendation letters, satisfying the Dhanasar prongs for NIW and extraordinary ability criteria for EB1A.

Request for Evidence (RFE)

Successfully Addressed

The RFE targeted the EB1A petition's evidence of extraordinary ability. The firm responded with compelling documentation of the client's influence and achievements, resulting in approval.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Healthcare · Iran

WeGreened EB-2 (NIW) approved
USA 141 days 2025-04-03
The petitioner proposes to investigate the molecular mechanisms underlying cardiovascular diseases to translate these insights into new pharmaceutical therapies. The work involves conducting research within U.S. academic environments to develop treatment paths that minimize invasive procedures and improve cardiovascular outcomes.
View Case

Others

Healthcare · Nigeria

WeGreened EB-2 (NIW) approved
South Carolina 220 days 2022-01-11
The petitioner proposes to continue investigating the impact of microRNA 33a, COVID-19, and ABCA1 and ABCG1 transporter genes on vascular smooth muscle cell activity. This research aims to facilitate the development of novel treatments for atherosclerosis and mitigate the impact of cardiovascular diseases on public health.
View Case

Researcher

Biotechnology · Brazil

WeGreened EB-2 (NIW) approved
126 days 2022-03-29
The petitioner proposes to continue her research on cardiovascular disease to facilitate the development of novel treatments and improve existing therapeutic approaches. Her work specifically focuses on elucidating the pathophysiology of cardiovascular diseases to advance next-generation medical interventions.
View Case

Doctor

Healthcare · China

WeGreened EB-2 (NIW) approved
321 days 2025-05-01
The petitioner proposes to continue her research into the molecular mechanisms underlying cardiovascular disease, specifically focusing on the gut microbiota's role in hypertension and the STING pathway in aortic dissection. Her work involves developing innovative gene therapies for heart regeneration and identifying novel molecular targets to improve patient outcomes. The endeavor aims to advance therapeutic interventions for complex cardiovascular conditions within U.S. medical research settings.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-08-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 311 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist